Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Steve Yankers should be nominated as a director of BIEL!
exactly bieliever - I also want to know what GRO-International has done since that company was announced on Valentine's Day, the results for BIEL of those efforts, and what it intends to do in the next 12 months.
I just hope the MM's who picked up 339 Million shares last week and so far this week run it hard - Go MM's!!!
And those who bought and sold 1.487 Billion shares since Valentine's Day - the products work - run it so management can fund growth properly! Thanks.
me too fuente - cheers
You're not going anywhere fuente, at least not very far. You know the technology along with a lot of other posters and that the products work. I am going to assume that Whelan and others on his team at BIEL have learned a critical lesson - don't fight City Hall.
Hopefully they have become sophisticated enough to give the FDA what it needs to approve ActiPatch and Allay because they are both winners, ActiPatch because I have used it and Allay because of the data. They screwed up a lot along the learning curve, but the products didn't.
Cheers
Your choice fuente - I read it this way.
We always knew Whelan was playing with fire by alienating the folks at the FDA by challenging their decisions with the office of the Integrity Commissioner. That's like asking someone to do a report card on his boss, suicidal.
So the Commish says "nope, not gonna interfere, if you want approval, go through normal channels". And that's where we are, including being part of the FDA look at the whole PMF device review. I'm not saying this stock is going to be 10 cents soon, or anytime. But it seems to me there are shares being sold and bought and probably the MM's are making out like bandits. Whelan's PR says they are in business in many countries, I expect the management of the company to work at advancing the company.
I know the product ActiPatch works, the company's job is to prove to the FDA efficacy and safety - so do it. This is not snake oil as one person has said, it is a series of devices following RecoveryRx which was approved as an Rx product by the FDA. Good luck fuente
thanks stock
Hey stock - do you agree with BurntToast on the .0011 entry point to load some in and average way down? Or, would you recommend waiting till it drops more, if you think it will, or, until after R/S if you still believe after the PR that R/S will happen as you have often said? I know many things can change in seconds, I'm just wondering what your take is as things develop.
Whelan says he has sold 500,000 devices globally, I'm also wondering how repeat business with those users might affect things - it's in lot of countries. Do you have global thoughts?
Thanks to you and Walker on the patent info Super - USPTO site is not easy and patent # helps.
thanks very much bieliever - thought I recalled seeing a number somewhere - I wonder if this is the RecoveryRx Patent and Allay and ActiPatch are additions to it?
Hey super - give me a #7 well done and a dozen of the #14's well done to go......please.
7). Had spikes in pps generated by Pump and Dump artist firms.
14). Even used celebrities to try to convince people of validity
Seriously, has anyone seen patent numbers, I seem to recall something.
The packaging I kept show "U.S. and Foreign Patents Pending" and then "Health Canada Medical Device License No. 73574", but the pack is a few years old and was sent to me by a college buddy up in Toronto. We can't get BIEL products here in the USA, so I have no idea what the current packaging says. Patent pending isn't all bad, it can mean the patent isn't yet issued so it's in the applied for state - also means people can't get a copy of it yet.
Sooooo stocker - I see you published the data I asked you for again. Let's be clear. I asked you for the data, you kindly provided it as you are the Guru of such things and I am not. That makes you my consultant, and my check is in the mail. BUT, I retain and own the copyright to the assemblage of that data, so please cease and desist.....you like my data, don't you.....
All in jest, thanks again..(you really like my data huh?)
Thanks very much stock. I had no idea where to go to get the data, not my area.
As I said yesterday, you're a smart fella, so you already know where I'm going in my quest for a better viewpoint and the truth.
Shares traded Feb 14th incl - June 6th incl same day totals - 2011, 2012, 2013
2013 1,336,700,306
2012 57,270,983
2011 2,364,318
Volume in 2012 was 24X the same period in 2011
2013 was 23X 2012
2013 was 565X the same period in 2011
Casper has a pretty good handle on things and the Kid crunches financials for a living.
My question is simple - Whatsup?
And this layman's observation is even more simple..... things happen for a reason.
BIEL is still before the FDA, the June 6 PR states that in addition to their 6 already published medical journey studies the company has 11 other ongoing trials and studies in process. It seems to me that the Engineer and technical folks at BIEL are running a good program of proving to the FDA that they have the goods.
I would love to know your thoughts, as well as Casper's and the Kids. Mad, give me your take as well please and whatever the chirper has to say too.
Can anyone advise how many BIEL shares traded between February 14 and June 6 20111, and between February 14 and June 6, 2012 and this year between February 14 to June 6, 2013?
Stock, you seem to be a pretty bright fella with a ton of opinions, all recommending shareholders sell and take their losses. You also wrote that Whelan has sold a billion shares into the market over the past few months. So, if you are correct in stating repeatedly that BIEL is on its way to triple zeroes and I will be able to buy in at .0006, then why would anyone be stupid enough to buy knowing that? And why would anyone be stupid enough to buy into a stock that has gone from $.0066 to $.0014 in just a few months and has actually dropped 66% since March 25 when it traded at .0047? Why?
Because, as has apparently been the case for four years, they are selling shares to fund the operation, studies, trials, rent, etc., etc. Not my theory, but the opinion of many posters.
I'm no conspiracy theorist - and my logic says it's either MM's playing the game to catch a crumb here and there, which on an annual basis can be lucrative but not usually on a stock like BIEL which has not been volatile for a couple of years, or real buyers accumulating for reasons I am unaware of unless it is because the products work and there is upside.
Someone sold more than 83 million shares today, but someone also bought them too.
The first part I know about, if I believe all the posters about dilution. But, I have also wondered for a long time, a few months of higher trading numbers since the Feb 14 announcement of the GRO-International deal, about cooperation between parties to allow shares to be purchased at lowball prices.
So, who is buying and why? Hundreds of millions of shares bought by ??? Market Makers? Day traders? I don't buy either of those two as they would have no assurance of making much with little volatility.
You're right Super - it's all BS
You say BIEL doesn't know how to sell products without FDA approval - I'm not sure they do with approval, like up in Canada where they have already had the approval to sell the products OTC for a few years. I have my old College buddy up there in Toronto who originally sent me a few ActiPatch for an injury and he's pretty connected. I should ask him if he can find out what the BIEL track record is up there.
And what about the other 20 or more countries where BIEL can sell OTC through its distributors, what's been happening with all of them? I would like to go forward not backwards, but like you Super, it makes no sense to me for someone to just whine, "they all tell us show me demand and I'll stock it". Retailers are risk takers and based on the Dr. Oz show response and internet ratings of BIEL, deals should have been happening for more than a couple of years. And has anyone seen any activities relating to Gro-International? Hey Madp, is the cover on the birdie's cage in the daytime too? What's the latest you hear my friend?
Sure it will be your last post.
Foot in the door, I repeat my nomination: Steve for President of BIEL - Andy, you can keep the Chairmanship, just sit back, enjoy the ride, and let Steve make you very wealthy!!!!
And Steve, you will let us know how you are and how you are doing, the good guys here (M&F) will know where you are.
First order of business, a professional PR announcing Steve's addition to the BIEL Sales & Marketing team for development of the equine and pet markets in the USA - music to these ears! Congrats Steve.
Financing BIEL is not rocket science - would do it myself.
Mr. Whelan, you pledge every share you and friends and family own, plus your IP, plus your inventory, FF&E and receivables and a personal guarantee, plus your sister Mary, and I put half a million in - I would do that deal all day long. Many on this board already have that much skin in the game without the collateral. But, IMO for an institution to come into play now, something may be up. I don't need to know what that may be, just the presence of the paper is positive, particularly immediately following the FDA meeting. Seems to me that just the fact that an institution will play should raise the price, especially these days when financing is so difficult to complete anywhere in the world. Hard to bash this news.
Why not be gracious to those who wish to permanently or temporarily choose the sidelines? Anything else would be bitterness and that's not me. Doesn't mean I agree with them, just that I'm not begrudging about it.
Cheers Super - keep an eye on us and the price
Well done stevo
I nominate again - Steve for president of ActiPet
Also as member of BOD of BIEL!!
Then I truly don't get it - based on just ActiPet sales potential, this thing should be at a couple of cents.
Anyone know enough about the pet business to assess number of potential patients, frequency of use, sales, etc.? Wouldn't it be something if the potential of ActiPet is greater than ActiPatch for humans in the USA, that would be really embarrassing!!!
Thanks kid, but other questions come to mind. The slowness at the FDA is affecting numerous firms in the PEMF space, how can this be remedied? If BIEL were to commence a real and serious push into the Vet industry, both Vet Docs and retail, how foolish does that make our drug regulatory agency when BIEL products are okay for human use OTC in 40 countries, including the UK and Canada, but only pets here at home?
This could easily go from slow to feeble-minded pretty quickly, no?
When you indicate that better clinical data is required, how can it be that every firm waiting for the FDA, not just BIEL which we are all frustrated with, has bungled the FDA requirements for OTC approval?
As I have asked and said before finish, many multi-national pharmacos have vet divisions. Why is BIEL not a target for them for the sale of ActiPatch for pets in the USA? Unregulated, proven efficacy, pets often treated better than humans and the Vet Docs make money too. Sell ActiPatch or ActiPet online, in drug stores, Walmart, Vet Docs, 7Eleven, who cares? How many dogs and cats are there in this country? Seems every dog I see over 8 years old looks in pain. Steve for Pres of ActiPet!
But Steve, don't you agree that at 10 cents and beyond Whelan makes a ton more?
Would appreciate your take on this. Is the price being kept here by Whelan deliberately as part of a longer term agenda? This makes no sense for him at all!
If this PR had been about any other subject but PEMF and FDA, it would have been a game-changer and have affected the price five or ten-fold. Best I can think of is Whelan somehow using some of the money raised by dilution to do whatever it takes to get off the Pinks, hire a world-class PR firm and release whatever GRO-International has been up to. I remain convinced the Pinks is not the place to be at all! I'm wondering if Whelan really is an American with the standard winning attitude required for success.
A $2.00 trade? Just tell me thow long you want the bridge to be and I'll find one to sell you. Failing that, I have some great land in the everglades you can buy, just needs a little draining. Just joking kid, you know what I mean. Up and down 10% on a $2 trade, what should have happened with 94 shares million traded?
You're absolutely correct kid
For example, the last few minutes.
A sale of 5,000 shares of BIEL a few minutes ago worth $9.00, yes, $9.00, can lower the share price by 10% from $.0020 to $.0018, but transactions involving 94,082,159 on May 13 did not raise the share price at all, closing at a price of $.0018. How incredible is this?
As always, someone is buying the shares, but the price remains depressed? Hundreds of millions in the last couple of months. If it is more than market makers trading the crumbs and accumulating profits, how come?
I have believed for a long time that, on balance, the share price should be in the 10 to 20 cent range, before FDA rulings and before any run-up prior to meetings etc.
Do I have any specific mathematics to substantiate this? No. Can anyone provide evidence supporting or rejecting this? No.
If the info that the Whelans have converted debt to shares and made profit upon selling those shares into the market can be substantiated, then my question is what was done with the proceeds.
If the funds were somehow used to keep the company operation going, wonderful. If the funds were kept as personal gain, then they would have been taxed. Hopefully such activities are reviewed and hopefully they are done with so that the price of the shares can rise appropriately.
From all I see the Whelans want the company to thrive. Can't see any reason for going through all this for $250,000, $25 million or $250 million maybe, but not $250,000. Makes no sense.
To you and Phonenix, bieliever -
I like the double play sizzle of both modalities happening.
If it catches on, is it lost on anyone that maybe, just maybe BIEL has nailed it here by having the patent clock start again and new patent life the result?
Also, they may wel be continuing the monthly, daily dilution to raise operating funds but folks are buying the hundreds of millions of shares too! I know it's back-a-wards, but I have a lot of patience and BIEL is only one of hundreds,perhaps thousands of firms waiting on the FDA. Wouldn't those be interesting statistical facts? How many apps, how many applicants, average wait time, cost to economy? We maintain every statistic know to mankind for baseball and every other sport, exciting or mundane, I'd love to see a truthful FDA scorecard, it would never see the light of day, I'll bet.
It strikes me as curious that FDA's Dr. Maisel avails himself of the oldest profession on earth, one which is legal in many countries and one which provides in many cases a therapeutic and beneficial service. It is evidence of the newness of our country for Americans to judge others on such personal and private matters, with no knowledge as to the cause of the needs for such services. Perhaps this man's wife is terminally ill? If so, and if pain is involved, he should pick up a case of ActiPatch for her. Whatever, none of our, or the states, business. Consenting adults. I have always suspected that the profession was deemed a scourge because money or barter goods were going to other than the church or tribal chiefs.
What does bother me is that the good doctor cannot see that PEMF, while newer than his chosen side-interest, is also therapeutic, effective and totally without negative side-effects - I strongly doubt anyone has picked up anything from an ActiPatch. Come over to the bright side from the dark side Doc.
It's a good thing for us that many companies are being jerked around by the FDA inability to assess PEMF and not just BIEL. Does anyone know how many of the estimated additional need for 200 people to handle device assessment at the FDA were actually hired?
Thanks
Thanks Casper - I'm comfortable with anything between 15 and 25 cents because if the application to the FDA in 2009 had legs then, I think it is reasonable to say that it would have gone to above the 12 cent mark instead of fizzling out as it did. Pure speculation, therefor nonsense as to what level it may have reached - 15 cents? 25 cents? Who knows.
I think now the company has better legs - more products, especially ALLAY which was in its infancy 4 years ago.
Also, devices and PEMF are seemingly here to stay and there are other companies impugned by the FDA delays - maybe it is BIEL's time to shine - I hope so, because the public is sick of being poisoned by painkiller drugs.
Thanks disciple - I do keep it I mind - this way.
If it ran to just over 12 cents in 2009 with 1/6th the number of shares as compared to today, ask yourself this question.
Given that it ran to 12 cents on nothing but promoted air regarding 'potential' FDA approval in 2009, is it conceivable that it could have gone to a buck or more then? Apparently so.
Is it reasonable then to think that it could run to 1/6th of its potential in 2009 now. I say yes. So, if that is 16 cents or so, I'm happy, north of there and I'm happier still. Could it go to a dollar now, nonsense!
One thing I cannot recall - was the hype in 2009 based on FDA OTC approval or some other lesser approval? Something tells me it was not OTC approval they were after then, am I forgetting something?
Thanks
I just don't know.....
Today I predicted the price would be .0032 to .0034 and a volume of 20 to 25 million shares traded.
Now I see it is .029 and 30.715 million shares.
Can't seem to get anything right
No wonder I felt BIEL could reach at least where it ran to in 2009, just over 12 cents, based on todays greater upside potential than then. Stupid me.
Go to the head of the class band5 - 18 1/2 million shares, a high of .0029 and it's 11:15AM........
My guess - .0032 to .0034 and 20 to 25 million shares
Just wondering about the placement of the decimal by steeleye and yourself finish.
Not many years ago BIEL ran from .0040 to 12.5 cents on much less horsepower than it presently may have. Then, it was hyped on FDA promise by a hustler who had no idea of the process, funding and time required along with the stamina of investors, public or private.
And here we are, a few years later, still alive, product still works beautifully, product line increased, not one negative side-effect, ever and still waiting on the FDA and company management to get on with it and allow the American public, the biggest market, to purchase ActiPatch and ALLAY OTC.
I recall when Zantac hit the market as an Rx drug for the treatment and prevention of recurring stomach and intestinal ulcers. Hundreds of millions spent on that approval, I knew someone in the pharma space who was involved. Now it is an antacid for indigestion, taken by the handful, much like candy. Nothing I know to do with BIEL, but an example of the absurdity.
Based on the BIEL products, the market here in the US and the drug-free aspects, I am optimistic this thing will blow through .0090 gaining momentum. Why not? And, if it does get regulatory traction, it will fly here and overseas with the dozens of distributors in place. FDA approval means something special globally.
Careful - Whelan may just fill the order
J&J and P&G enter the bidding war for BIEL
2 days? How about 10.7 mill, 15.8, 21.2, 38.9 last 4 days?